|
BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease
|
BioMarin |
|
Results of Chaperone/ERT Study Expected for Second Half of 2011
|
Amicus |
|
Request to pay for life-saving drug rejected
|
Press |
|
Life saving drug rejected for Wagga woman
|
Press |
|
Discussion of benefit and cost of therapies for rare disorders in Switzerland
|
Press |
|
Pompe sufferer has bid rejected
|
Press |
|
Sick dad's hopes crushed as $500,000 drug left out of Australia's Lifesaving Drugs Program
|
Press |
|
Court rejects reimbursement for adult Pompe patient in Switzerland
|
Press |
|
Survivor joins fight for vital drug
|
Press |
|
BioMarin Receives Orphan Drug Designation for Pompe Disease from the FDA
|
BioMarin |
